Literature DB >> 11905608

FDA licences imatinib mesylate for CML.

Martina Habeck.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11905608     DOI： 10.1016/s1470-2045(01)00608-8

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  8 in total

1.  Progress against cancer (1971-2011): how far have we come?

Authors:  A K Tiwari; H K Roy
Journal:  J Intern Med       Date:  2011-10-20       Impact factor: 8.989

2.  Regorafenib regresses an imatinib-resistant recurrent gastrointestinal stromal tumor (GIST) with a mutation in exons 11 and 17 of c-kit in a patient-derived orthotopic xenograft (PDOX) nude mouse model.

Authors:  Kentaro Miyake; Kei Kawaguchi; Tasuku Kiyuna; Masuyo Miyake; Kentaro Igarashi; Zhiying Zhang; Takashi Murakami; Yunfeng Li; Scott D Nelson; Irmina Elliott; Tara Russell; Arun Singh; Yukihiko Hiroshima; Masashi Momiyama; Ryusei Matsuyama; Takashi Chishima; Itaru Endo; Fritz C Eilber; Robert M Hoffman
Journal:  Cell Cycle       Date:  2018       Impact factor: 4.534

3.  Non-small-cell lung cancer: molecular targeted therapy and personalized medicine - drug resistance, mechanisms, and strategies.

Authors:  Marybeth Sechler; Amber D Cizmic; Sreedevi Avasarala; Michelle Van Scoyk; Christine Brzezinski; Nicole Kelley; Rama Kamesh Bikkavilli; Robert A Winn
Journal:  Pharmgenomics Pers Med       Date:  2013-04-04

Review 4.  The challenges and the promise of molecular targeted therapy in malignant gliomas.

Authors:  Hongxiang Wang; Tao Xu; Ying Jiang; Hanchong Xu; Yong Yan; Da Fu; Juxiang Chen
Journal:  Neoplasia       Date:  2015-03       Impact factor: 5.715

Review 5.  Convection-enhanced Delivery of Therapeutics for Malignant Gliomas.

Authors:  Ryuta Saito; Teiji Tominaga
Journal:  Neurol Med Chir (Tokyo)       Date:  2016-12-15       Impact factor: 1.742

Review 6.  Liquid biopsies and cancer omics.

Authors:  Ivano Amelio; Riccardo Bertolo; Pierluigi Bove; Oreste Claudio Buonomo; Eleonora Candi; Marcello Chiocchi; Chiara Cipriani; Nicola Di Daniele; Carlo Ganini; Hartmut Juhl; Alessandro Mauriello; Carla Marani; John Marshall; Manuela Montanaro; Giampiero Palmieri; Mauro Piacentini; Giuseppe Sica; Manfredi Tesauro; Valentina Rovella; Giuseppe Tisone; Yufang Shi; Ying Wang; Gerry Melino
Journal:  Cell Death Discov       Date:  2020-11-26

Review 7.  Angiogenesis and its therapeutic opportunities.

Authors:  So Young Yoo; Sang Mo Kwon
Journal:  Mediators Inflamm       Date:  2013-07-28       Impact factor: 4.711

8.  Tumor-targeting Salmonella typhimurium A1-R suppressed an imatinib-resistant gastrointestinal stromal tumor with c-kit exon 11 and 17 mutations.

Authors:  Kentaro Miyake; Kei Kawaguchi; Masuyo Miyake; Ming Zhao; Tasuku Kiyuna; Kentaro Igarashi; Zhiying Zhang; Takashi Murakami; Yunfeng Li; Scott D Nelson; Michael Bouvet; Irmina Elliott; Tara A Russell; Arun S Singh; Yukihiko Hiroshima; Masashi Momiyama; Ryusei Matsuyama; Takashi Chishima; Shree Ram Singh; Itaru Endo; Fritz C Eilber; Robert M Hoffman
Journal:  Heliyon       Date:  2018-06-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.